Randomised clinical trial: the efficacy and safety of pancreatin enteric‐coated minimicrospheres ( <scp>C</scp> reon 40000 <scp>MMS</scp> ) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis ‐ a double‐blind, placebo‐controlled study

Abstract

The results provide evidence for the efficacy of pancreatin (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis, and confirm that this formulation is well tolerated, with a good safety profile, at the dose administered.